{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:28:58Z","timestamp":1793672938348,"version":"4.5.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00347-019-0870-x","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T14:04:46Z","timestamp":1550844286000},"page":"942-950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Grundz\u00fcge der medikament\u00f6sen Therapie und chirurgische Optionen bei Uveitis","Pharmacological treatment strategies and surgical options for uveitis"],"prefix":"10.1007","volume":"116","author":[{"given":"Justus G.","family":"Garweg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/OPTH.S121734","volume":"11","author":"C You","year":"2017","unstructured":"You C, Sahawneh HF, Ma L, Kubaisi B, Schmidt A, Foster CS (2017) A review and update on orphan drugs for the treatment of noninfectious uveitis. Clin Ophthalmol 11:257\u2013265","journal-title":"Clin Ophthalmol"},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2015.07.001","volume":"61","author":"CS Foster","year":"2016","unstructured":"Foster CS, Kothari S, Anesi SD, Vitale AT, Chu D, Metzinger JL, Cer\u00f3n O (2016) The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. Surv Ophthalmol 61:1\u201317","journal-title":"Surv Ophthalmol"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.ophtha.2015.10.056","volume":"123","author":"AK Patel","year":"2016","unstructured":"Patel AK, Newcomb CW, Liesegang TL, Pujari SS, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Artornsombudh P, Kothari S, Kempen JH (2016) Systemic immunosuppressive therapy for eye diseases research group. Risk of retinal neovascularization in cases of uveitis. Ophthalmology 123:646\u2013654","journal-title":"Ophthalmology"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","volume":"125","author":"AD Dick","year":"2018","unstructured":"Dick AD, Rosenbaum JT, Al-Dhibi HA, Belfort R Jr., Br\u00e9zin AP, Chee SP, Davis JL, Ramanan AV, Sonoda KH, Carre\u00f1o E, Nascimento H, Salah S, Salek S, Siak J, Steeples L, Fundamentals of Care for Uveitis International Consensus Group (2018) Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for UveitiS (FOCUS) initiative. Ophthalmology 125:757\u2013773","journal-title":"Ophthalmology"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/ceo.12916","volume":"45","author":"HJ Kwon","year":"2017","unstructured":"Kwon HJ, Kong YXG, Tao LW, Lim LL, Martin KR, Green C, Ruddle J, Crowston JG (2017) Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity. Clin Exp Ophthalmol 45:472\u2013480","journal-title":"Clin Exp Ophthalmol"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1055\/s-0043-123650","volume":"235","author":"JG Garweg","year":"2018","unstructured":"Garweg JG (2018) Macular edema in childhood uveitis. Klin Monbl Augenheilkd 235:373\u2013376","journal-title":"Klin Monbl Augenheilkd"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1080\/08820538.2017.1353815","volume":"33","author":"SM Llop","year":"2018","unstructured":"Llop SM, Papaliodis GN (2018) Cataract surgery complications in uveitis patients: a review article. Semin Ophthalmol 33:64\u201369","journal-title":"Semin Ophthalmol"},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3109\/09273948.2015.1134581","volume":"25","author":"K Durrani","year":"2017","unstructured":"Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS, Systemic Immunosuppressive Therapy For Eye Diseases Site Research Group. (2017) Adalimumab for Ocular Inflammation. Ocul Immunol Inflamm 25:405\u2013412","journal-title":"Ocul Immunol Inflamm"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2015.12.034","volume":"164","author":"JH Kempen","year":"2016","unstructured":"Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Ka\u00e7maz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD, Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group (2016) Remission of intermediate uveitis: incidence and predictive factors. Am J Ophthalmol 164:110\u2013117.e2","journal-title":"Am J Ophthalmol"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/art.27581","volume":"62","author":"CM Deuter","year":"2010","unstructured":"Deuter CM, Zierhut M, M\u00f6hle A, Vonthein R, St\u00f6biger N, K\u00f6tter I (2010) Long-term remission after cessation of interferon-\u03b1 treatment in patients with severe uveitis due to Beh\u00e7et\u2019s disease. Arthritis Rheum 62:2796\u20132805","journal-title":"Arthritis Rheum"},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.4049\/jimmunol.172.11.7086","volume":"172","author":"NS Bora","year":"2004","unstructured":"Bora NS, Sohn JH, Kang SG, Cruz JM, Nishihori H, Suk HJ, Wang Y, Kaplan HJ, Bora PS (2004) Type I collagen is the autoantigen in experimental autoimmune anterior uveitis. J\u00a0Immunol 172:7086\u20137094","journal-title":"J Immunol"},{"key":"870_CR12","doi-asserted-by":"publisher","first-page":"31401","DOI":"10.1074\/jbc.M109.033381","volume":"284","author":"P Jha","year":"2009","unstructured":"Jha P, Manickam B, Matta B, Bora PS, Bora NS (2009) Proteolytic cleavage of type I collagen generates an autoantigen in autoimmune uveitis. J\u00a0Biol Chem 284:31401\u201331411","journal-title":"J Biol Chem"},{"key":"870_CR13","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1167\/iovs.15-16883","volume":"56","author":"H Asnagli","year":"2015","unstructured":"Asnagli H, Jacquin M, Belmonte N, Gertner-Dardenne J, Hubert MF, Sales A, Fall PB, Ginet C, Marchetti I, M\u00e9nard F, Lara G, Bobak N, Foussat A (2015) Inhibition of noninfectious uveitis using intravenous administration of collagen II-specific type 1 regulatory T cells. Invest Ophthalmol Vis Sci 56:6456\u20136466","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"870_CR14","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1517\/14656566.2014.948417","volume":"15","author":"K Lee","year":"2014","unstructured":"Lee K, Bajwa A, Freitas-Neto CA, Metzinger JL, Wentworth BA, Foster CS (2014) A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I. Expert Opin Pharmacother 15:2141\u20132154","journal-title":"Expert Opin Pharmacother"},{"key":"870_CR15","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s10067-016-3426-3","volume":"35","author":"C Fabiani","year":"2016","unstructured":"Fabiani C, Vitale A, Lopalco G, Iannone F, Frediani B, Cantarini L (2016) Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art. Clin Rheumatol 35:2631\u20132638","journal-title":"Clin Rheumatol"},{"key":"870_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/0301-4738.114103","volume":"61","author":"SI Murthy","year":"2013","unstructured":"Murthy SI, Pappuru RR, Latha KM, Kamat S, Sangwan VS (2013) Surgical management in patient with uveitis. Indian J Ophthalmol 61:284\u2013290","journal-title":"Indian J Ophthalmol"},{"key":"870_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/ICU.0000000000000441","volume":"29","author":"VS Sangwan","year":"2018","unstructured":"Sangwan VS, Gupta S, Das S (2018) Cataract surgery in ocular surface diseases: clinical challenges and outcomes. Curr Opin Ophthalmol 29:81\u201387","journal-title":"Curr Opin Ophthalmol"},{"key":"870_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jcjo.2016.10.007","volume":"52","author":"H Chiu","year":"2017","unstructured":"Chiu H, Dang H, Cheung C, Khosla D, Arjmand P, Rabinovitch T, Derzko-Dzulynsky L (2017) Ten-year retrospective review of outcomes following phacoemulsification with intraocular lens implantation in patients with pre-existing uveitis. Can J Ophthalmol 52:175\u2013180","journal-title":"Can J Ophthalmol"},{"key":"870_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1136\/bjophthalmol-2016-309047","volume":"101","author":"CJ Chu","year":"2017","unstructured":"Chu CJ, Dick AD, Johnston RL, Yang YC, Denniston AK, UK Pseudophakic Macular Edema Study Group. (2017) Cataract surgery in uveitis: a\u00a0multicentre database study. Br J Ophthalmol 101:1132\u20131137","journal-title":"Br J Ophthalmol"},{"key":"870_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.4103\/ijo.IJO_740_17","volume":"65","author":"NS Chan","year":"2017","unstructured":"Chan NS, Ti SE, Chee SP (2017) Decision-making and management of uveitic cataract. Indian J Ophthalmol 65:1329\u20131339","journal-title":"Indian J Ophthalmol"},{"key":"870_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/ICU.0000000000000438","volume":"29","author":"MD Conway","year":"2018","unstructured":"Conway MD, Stern E, Enfield DB, Peyman GA (2018) Management of cataract in uveitis patients. Curr Opin Ophthalmol 29:69\u201374","journal-title":"Curr Opin Ophthalmol"},{"key":"870_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007284","author":"TG Leung","year":"2014","unstructured":"Leung TG, Lindsley K, Kuo IC (2014) Types of intraocular lenses for cataract surgery in eyes with uveitis. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD007284","journal-title":"Cochrane Database Syst Rev"},{"key":"870_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ajo.2014.06.018","volume":"158","author":"S Mehta","year":"2014","unstructured":"Mehta S, Linton MM, Kempen JH (2014) Outcomes of cataract surgery in patients with uveitis: a\u00a0systematic review and meta-analysis. Am J Ophthalmol 158:676\u2013692.e7","journal-title":"Am J Ophthalmol"},{"key":"870_CR24","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5935\/0004-2749.20170025","volume":"80","author":"PMG Cerqueira","year":"2017","unstructured":"Cerqueira PMG, Silva FTBGCD, Carricondo PC, Olivalves E, Hirata CE, Yamamoto JH (2017) Outcomes of phacoemulsification in patients with uveitis at a\u00a0tertiary center in S\u00e3o Paulo, Brazil: a\u00a0review of cases from 2007 to 2012. Arq Bras Oftalmol 80:104\u2013107","journal-title":"Arq Bras Oftalmol"},{"key":"870_CR25","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2147\/DDDT.S138922","volume":"11","author":"V Bonfiglio","year":"2017","unstructured":"Bonfiglio V, Reibaldi M, Fallico M, Russo A, Pizzo A, Fichera S, Rapisarda C, Macchi I, Avitabile T, Longo A (2017) Widening use of dexamethasone implant for the treatment of macular edema. Drug Des Devel Ther 11:2359\u20132372","journal-title":"Drug Des Devel Ther"},{"key":"870_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1089\/jop.2016.0035","volume":"32","author":"JG Garweg","year":"2016","unstructured":"Garweg JG, Baglivo E, Freiberg FJ, Pfau M, Pfister IB, Michels S, Zandi S (2016) Response of postoperative and chronic uveitic cystoid macular edema to a\u00a0dexamethasone-based Intravitreal implant (Ozurdex). J\u00a0Ocul Pharmacol Ther 32:442\u2013450","journal-title":"J Ocul Pharmacol Ther"},{"key":"870_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12824","volume":"1358","author":"SM Whitcup","year":"2015","unstructured":"Whitcup SM, Robinson MR (2015) Development of a\u00a0dexamethasone intravitreal implant for the treatment of noninfectious posterior segment uveitis. Ann N Y Acad Sci 1358:1\u201312","journal-title":"Ann N Y Acad Sci"},{"key":"870_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ajo.2016.03.049","volume":"166","author":"MB Larochelle","year":"2016","unstructured":"Larochelle MB, Smith J, Dacey MS (2016) Dexamethasone intravitreal implant in the treatment of Uveitic macular edema in the perioperative cataract setting: a case series. Am J Ophthalmol 166:149\u2013153","journal-title":"Am J Ophthalmol"},{"key":"870_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1089\/jop.2015.0009","volume":"31","author":"AP Ragam","year":"2015","unstructured":"Ragam AP, Kolomeyer AM, Nayak NV, Chu DS (2015) The use of ozurdex (dexamethasone intravitreal implant) during anterior segment surgery in patients with chronic recurrent uveitis. J\u00a0Ocul Pharmacol Ther 31:344\u2013349","journal-title":"J Ocul Pharmacol Ther"},{"key":"870_CR30","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1097\/IAE.0000000000001063","volume":"36","author":"A Zheng","year":"2016","unstructured":"Zheng A, Chin EK, Almeida DR, Tsang SH, Mahajan VB (2016) Combined vitrectomy and intravitreal dexamethasone (Ozurdex) sustained-release implant. Retina 36:2087\u20132092","journal-title":"Retina"},{"key":"870_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/bs.pbr.2015.06.008","volume":"221","author":"CC Sng","year":"2015","unstructured":"Sng CC, Ang M, Barton K (2015) Uveitis and glaucoma: new insights in the pathogenesis and treatment. Prog Brain Res 221:243\u2013269","journal-title":"Prog Brain Res"},{"issue":"4","key":"870_CR32","first-page":"584","volume":"26","author":"DC Gritz","year":"2018","unstructured":"Gritz DC, Schwaber EJ, Wong IG (2018) Complications of uveitis: the northern california epidemiology of uveitis study. Ocul Immunol Inflamm 26(4):584\u2013594","journal-title":"Ocul Immunol Inflamm"},{"key":"870_CR33","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jcrs.2010.10.051","volume":"37","author":"DF Chang","year":"2011","unstructured":"Chang DF, Tan JJ, Tripodis Y (2011) Risk factors for steroid response among cataract patients. J\u00a0Cataract Refract Surg 37:675\u2013681","journal-title":"J Cataract Refract Surg"},{"key":"870_CR34","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3109\/09273948.2015.1047036","volume":"24","author":"K Rubaie Al","year":"2016","unstructured":"Al Rubaie K, Al Dhahri H, Al Fawaz A, Hemachandran S, Mousa A, Mohamed AG, Al-Obeidan SA, El-Asrar AAM (2016) Incidence and risk factors for developing glaucoma among patients with uveitis in a\u00a0university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm 24:571\u2013578","journal-title":"Ocul Immunol Inflamm"},{"key":"870_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3109\/02713683.2015.1017650","volume":"41","author":"AJ Baneke","year":"2016","unstructured":"Baneke AJ, Lim KS, Stanford M (2016) The pathogenesis of raised Intraocular pressure in uveitis. Curr Eye Res 41:137\u2013149","journal-title":"Curr Eye Res"},{"key":"870_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10384-015-0372-6","volume":"59","author":"SM Iverson","year":"2015","unstructured":"Iverson SM, Bhardwaj N, Shi W, Sehi M, Greenfield DS, Budenz DL, Kishor K (2015) Surgical outcomes of inflammatory glaucoma: a\u00a0comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol 59:179\u2013186","journal-title":"Jpn J Ophthalmol"},{"key":"870_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/IJG.0000000000000539","volume":"26","author":"M Yakin","year":"2017","unstructured":"Yakin M, Eksioglu U, Sungur G, Satana B, Demirok G, Ornek F (2017) Short-term to long-term results of Ahmed glaucoma valve implantation for Uveitic glaucoma secondary to Beh\u00e7et disease. J\u00a0Glaucoma 26:20\u201326","journal-title":"J Glaucoma"},{"key":"870_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ajo.2012.05.011","volume":"154","author":"S Yeh","year":"2012","unstructured":"Yeh S, Albini TA, Moshfeghi AA, Nussenblatt RB (2012) Uveitis, the comparison of age-related macular degeneration treatments trials (CATT), and intravitreal biologics for ocular inflammation. Am J Ophthalmol 154:429\u2013435.e2","journal-title":"Am J Ophthalmol"},{"key":"870_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","volume":"129","author":"C Lowder","year":"2011","unstructured":"Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM, Ozurdex HURON Study Group (2011) Dexamethasone intravitreal implant for non-infectious intermediate or posterior uveitis. Arch Ophthalmol 129:545\u2013553","journal-title":"Arch Ophthalmol"},{"key":"870_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010469","author":"CJ Brady","year":"2016","unstructured":"Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC, Garg SJ, Tang J (2016) Corticosteroid implants for chronic non-infectious uveitis. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD010469","journal-title":"Cochrane Database Syst Rev"},{"key":"870_CR41","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/00055735-200312000-00014","volume":"14","author":"MJ Lustig","year":"2003","unstructured":"Lustig MJ, Cunningham ET Jr. (2003) Use of immunosuppressive agents in uveitis. Curr Opin Ophthalmol 14:399\u2013412","journal-title":"Curr Opin Ophthalmol"},{"key":"870_CR42","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/ICU.0b013e32834bbd68","volume":"22","author":"A Sallam","year":"2011","unstructured":"Sallam A, Taylor SR, Lightman S (2011) Review and update of intraocular therapy in noninfectious uveitis. Curr Opin Ophthalmol 22:517\u2013522","journal-title":"Curr Opin Ophthalmol"},{"key":"870_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1471-2415-13-39","volume":"13","author":"S Tempest-Roe","year":"2013","unstructured":"Tempest-Roe S, Joshi L, Dick AD, Taylor SR (2013) Local therapies for inflammatory eye disease in translation: past, present and future. BMC Ophthalmol 13:39","journal-title":"BMC Ophthalmol."},{"key":"870_CR44","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12348-014-0026-8","volume":"4","author":"I Pascual-Camps","year":"2014","unstructured":"Pascual-Camps I, Hern\u00e1ndez-Mart\u00ednez P, Monje-Fern\u00e1ndez L, Dolz-Marco R, Gallego-Pinazo R, Wu L, Ar\u00e9valo JF, D\u00edaz-Llopis M (2014) Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders. J\u00a0Ophthalmic Inflamm Infect 4:26","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"870_CR45","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.jcjo.2012.09.016","volume":"48","author":"C Or","year":"2013","unstructured":"Or C, Press N, Forooghian F (2013) Acute retinal necrosis secondary to cytomegalovirus following successful treatment of cytomegalovirus anterior uveitis in an immunocompetent adult. Can J Ophthalmol 48:e18\u2013e20","journal-title":"Can J Ophthalmol"},{"key":"870_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1097\/01.icu.0000434534.32063.5c","volume":"24","author":"RS Moorthy","year":"2013","unstructured":"Moorthy RS, London NJ, Garg SJ, Cunningham ET Jr. (2013) Drug-induced uveitis. Curr Opin Ophthalmol 24:589\u2013597","journal-title":"Curr Opin Ophthalmol"},{"key":"870_CR47","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3109\/09273948.2013.866256","volume":"22","author":"A Takakura","year":"2014","unstructured":"Takakura A, Tessler HH, Goldstein DA, Guex-Crosier Y, Chan CC, Brown DM, Thorne JE, Wang R, Cunningham ET Jr. (2014) Viral retinitis following intraocular or periocular corticosteroid administration: a\u00a0case series and comprehensive review of the literature. Ocul Immunol Inflamm 22:175\u2013182","journal-title":"Ocul Immunol Inflamm"},{"key":"870_CR48","doi-asserted-by":"publisher","first-page":"e813","DOI":"10.1111\/aos.13131","volume":"94","author":"AS Thrane","year":"2016","unstructured":"Thrane AS, Hove M, Kjersem B, Krohn J (2016) Acute retinal necrosis and ocular neovascularization caused by cytomegalovirus following intravitreal dexamethasone implant (Ozurdex(\u00ae) ) in an immunocompetent patient. Acta Ophthalmol 94:e813\u2013e814","journal-title":"Acta Ophthalmol"},{"key":"870_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5935\/0004-2749.20150030","volume":"78","author":"M Kucukevcilioglu","year":"2015","unstructured":"Kucukevcilioglu M, Eren M, Yolcu U, Sobaci G (2015) Acute retinal necrosis following intravitreal dexamethasone (Ozurdex\u00ae) implant. Arq Bras Oftalmol 78:118\u2013119","journal-title":"Arq Bras Oftalmol"},{"key":"870_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000444576","volume":"60","author":"C Boulagnon","year":"2016","unstructured":"Boulagnon C, Ducasse A, Patey M, Diebold MD, Arndt C (2016) Cytopathology of vitreous humor samples in routine practice. Acta Cytol 60:65\u201373","journal-title":"Acta Cytol"},{"key":"870_CR51","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ajo.2015.08.033","volume":"160","author":"R Mastropasqua","year":"2015","unstructured":"Mastropasqua R, Thaung C, Pavesio C, Lightman S, Westcott M, Okhravi N, Aylward W, Charteris D, da Cruz L (2015) The role of chorioretinal biopsy in the diagnosis of Intraocular Lymphoma. Am J Ophthalmol 160:1127\u20131132.e1","journal-title":"Am J Ophthalmol"},{"key":"870_CR52","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/IIO.0000000000000017","volume":"54","author":"A Jeroudi","year":"2014","unstructured":"Jeroudi A, Yeh S (2014) Diagnostic vitrectomy for infectious uveitis. Int Ophthalmol Clin 54:173\u2013197","journal-title":"Int Ophthalmol Clin"},{"key":"870_CR53","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/112067210601600414","volume":"16","author":"JG Garweg","year":"2006","unstructured":"Garweg JG, Wanner D, Sarra GM, Altwegg M, Loosli H, Kodjikian L, Halberstadt M (2006) The diagnostic yield of vitrectomy specimen analysis in chronic idiopathic endogenous uveitis. Eur J Ophthalmol 16:588\u2013594","journal-title":"Eur J Ophthalmol"},{"key":"870_CR54","doi-asserted-by":"publisher","first-page":"e9491","DOI":"10.1097\/MD.0000000000009491","volume":"97","author":"T Sato","year":"2018","unstructured":"Sato T, Kinoshita R, Taguchi M, Sugita S, Kaburaki T, Sakurai Y, Takeuchi M (2018) Assessment of diagnostic and therapeutic vitrectomy for vitreous opacity associated with uveitis with various etiologies. Medicine (Baltimore) 97:e9491","journal-title":"Medicine (Baltimore)"},{"key":"870_CR55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1089\/jop.2016.0142","volume":"33","author":"SV Branson","year":"2017","unstructured":"Branson SV, McClafferty BR, Kurup SK (2017) Vitrectomy for epiretinal membranes and macular holes in uveitis patients. J\u00a0Ocul Pharmacol Ther 33:298\u2013303","journal-title":"J Ocul Pharmacol Ther"},{"key":"870_CR56","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/sj.eye.6701845","volume":"20","author":"P Trittibach","year":"2006","unstructured":"Trittibach P, Koerner F, Sarra GM, Garweg JG (2006) Vitrectomy for juvenile uveitis: prognostic factors for the long-term functional outcome. Eye (Lond) 20:184\u2013190","journal-title":"Eye (Lond)"},{"key":"870_CR57","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1055\/s-2008-1045769","volume":"200","author":"J Messerli","year":"1992","unstructured":"Messerli J, K\u00f6rner F, Ruggli J (1992) Chronic uveitis: course after vitrectomy. Klin Monbl Augenheilkd 200:378\u2013381","journal-title":"Klin Monbl Augenheilkd"},{"key":"870_CR58","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/eye.2015.73","volume":"29","author":"L Pelegr\u00edn","year":"2015","unstructured":"Pelegr\u00edn L, de la Maza MS, Molins B, R\u00edos J, Ad\u00e1n A (2015) Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis. Eye (Lond) 29:943\u2013950","journal-title":"Eye (Lond)"},{"key":"870_CR59","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s00417-017-3705-y","volume":"255","author":"H Kang","year":"2017","unstructured":"Kang H, Lee MW, Byeon SH, Koh HJ, Lee SC, Kim M (2017) The clinical outcomes of surgical management of anterior chamber migration of a\u00a0dexamethasone implant (Ozurdex\u00ae). Graefes Arch Clin Exp Ophthalmol 255:1819\u20131825","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"870_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4103\/0974-9233.134687","volume":"21","author":"HA Al-Dhibi","year":"2014","unstructured":"Al-Dhibi HA, Al-Mahmood AM, Arevalo JF (2014) A systematic approach to emergencies in uveitis. Middle east Afr J Ophthalmol 21:251\u2013258","journal-title":"Middle east Afr J Ophthalmol"},{"key":"870_CR61","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.jfo.2013.12.014","volume":"37","author":"C Pochat-Cotilloux","year":"2014","unstructured":"Pochat-Cotilloux C, De Bats F, Nguyen AM, Benbouzid F, Malcl\u00e8s A, Denis P, Kodjikian L (2014) Rifabutin-associated bilateral uveitis: a\u00a0case report. J\u00a0Fr Ophtalmol 37:e115\u2013e117","journal-title":"J Fr Ophtalmol"},{"key":"870_CR62","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","volume":"17","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O, Oweira H, Petrausch U, Helbling D, Schmidt J, Mannhart M, Mehrabi A, Sch\u00f6b O, Giryes A (2017) Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a\u00a0systematic review. Expert Rev Anticancer Ther 17:387\u2013394","journal-title":"Expert Rev Anticancer Ther"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-0870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-019-0870-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-019-0870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:14:49Z","timestamp":1582330489000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-019-0870-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s00347-019-0870-x","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"22 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.G.\u00a0Garweg gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine vom Autor durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}